ResMed Inc. Form 8-K Summary
Business Context and Reporting Period
ResMed Inc. (NYSE: RMD) filed a Current Report on Form 8-K dated April 30, 2026. The filing reports on operational results for the quarter ended March 31, 2026, and announces a new quarterly cash dividend.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is not included in the provided text.
Material Changes and Corporate Actions
- Dividend Declaration: The Board of Directors declared a quarterly cash dividend of US $0.60 per share.
- Dividend Dates:
- Record Date: May 14, 2026
- Payment Date: June 18, 2026
- Ex-Dividend Date: May 13, 2026
- CDI Holders: Holders of CHESS Depositary Interests (CDIs) on the Australian Securities Exchange will receive an equivalent amount in Australian currency based on the record date exchange rate, reflecting a 10:1 ratio between CDIs and NYSE shares.
- ASX Waiver: ResMed received a waiver from ASX settlement rules to defer processing conversions between common stock and CDI registers from May 13, 2026, through May 14, 2026.
Guidance, Outlook, and Risks
The provided text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The filing states that the information in the attached press release (Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the specific revenue and earnings figures for the quarter ended March 31, 2026, by reviewing Exhibit 99.1 (Press Release).
- Confirm the exact Australian dollar dividend amount for CDI holders once the exchange rate on the record date (May 14, 2026) is established.
- Monitor the ex-dividend date of May 13, 2026, for trading implications on both NYSE and ASX markets.